Brequinar Combined With Dipyridamole in Patients With Mild to Moderate SARS-CoV-2 Infection.
Status:
Not yet recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
A Phase 2 multi-center, assessor-blind, randomized study to assess the safety, tolerability,
and antiviral activity of brequinar in combination with dipyridamole.